Parametric Portfolio Associates’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Parametric Portfolio Associates’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,846	Closed	-$82K	–	4000
2016 Q1	$82K	Buy	7,846 +4,972	+173%	+$98.8K	﹤0.01%	3884
2015 Q4	$85K	Buy	2,874 +70	+2%	+$2.12K	﹤0.01%	3872
2015 Q3	$89K	Buy	2,804 +421	+18%	+$20.1K	﹤0.01%	3201
2015 Q2	$141K	Sell	2,383 -1,552	-39%	-$109K	﹤0.01%	3830
2015 Q1	$421K	Buy	3,935 +1,474	+60%	+$140K	﹤0.01%	3372
2014 Q4	$231K	Sell	2,461 -128	-5%	-$12.2K	﹤0.01%	3712
2014 Q3	$199K	Sell	2,589 -385	-13%	-$30.3K	﹤0.01%	3613
2014 Q2	$267K	Buy	2,974 +296	+11%	+$18.1K	﹤0.01%	3582
2014 Q1	$143K	Buy	+2,678	New	+$88.4K	﹤0.01%	3697

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Parametric Portfolio Associates's PTX Position: Q2 2016 in Review

Parametric Portfolio Associates sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 7,846 shares — an estimated $82K sold.

Parametric Portfolio Associates first reported a position in PTX in Q1 2014 and held it in 9 quarters. The position peaked at $421K in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

Parametric Portfolio Associates reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Parametric Portfolio Associates sold 7,846 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $82K.
Parametric Portfolio Associates first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 9 quarters.
Parametric Portfolio Associates's Pernix Therapeutics Holdings, Inc. position peaked at $421K in Q1 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Parametric Portfolio Associates's 13F filing for Q2 2016, filed 12 Aug 2016.